Mark Humphrey
NGM Biopharmaceuticals (United States) · 11 works · 1,771 citations · h-index 8
Top works
- Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness
- Activity-based probes for the proteomic profiling of metalloproteases
- A streamlined platform for high-content functional proteomics of primary human specimens
- High speed detection of circulating tumor cells
- Case study of the morphologic variation of circulating tumor cells
- Carcinoma and stromal enzyme activity profiles associated with breast tumor growth in vivo
- Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19
- Glucagon-receptor-antagonism-mediated β-cell regeneration as an effective anti-diabetic therapy
- P0933 : NGM282 exhibits potent anti-inflammatory and anti-fibrotic activity in FXR-null mice with non-alcoholic steatohepatitis (NASH) histopathology
- Abstract LB230: Generation of a B7-H4-restricted LTBR agonist to induce tertiary lymphoid structure formation in solid tumors